What Does the Dow-DuPont Merger Mean for the Biomaterials Industry?

Late last year, American chemical conglomerates, Dow and DuPont, arrived at an agreement to merge and form a $130 billion company. This merger will split the new company into three firms focusing on agriculture, material science and specialty products such as biomaterials. However, a new analysis shows that this may not be the “merger of equals”. The core businesses of DuPont, like industrial biosciences, will be under-utilized with this merger and potentially be available for acquisition or spin-out. The industry is looking at large mergers and acquisitions to help add investor value faster and fill in gaps in their offerings, especially in high growth areas.

Read Full News At: http://www.researz.com/dow-dupont-merger-mean-biomaterials-industry


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s